Lista de obras -

A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.

artículo científico publicado en 2018

A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients

scientific article published on 14 January 2020

A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons.

artículo científico publicado en 2004

Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy.

artículo científico publicado en 2015

Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.

artículo científico publicado en 2016

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

artículo científico publicado en 2019

Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China

artículo científico publicado en 2015

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

artículo científico publicado en 2017

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

artículo científico publicado en 2020

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.

artículo científico publicado en 2015

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

artículo científico publicado en 2015

Circulating chemokine (C-X-C Motif) receptor 5+CD4+ T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection ⬇️

artículo científico publicado el 19 de agosto de 2013

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.

artículo científico publicado en 2005

Combination Therapy With Tenofovir and Peginterferon May Not Be Translated Into Current Clinical Practice.

artículo científico publicado en 2016

Commentary: prognostication of chronic hepatitis B ‐ are Fibrotest and Fibroscan the final answers? ⬇️

artículo científico publicado el 1 de junio de 2013

Complementarity-determining region 3 size spectratypes of T cell receptor beta chains in CD8+ T cells following antiviral treatment of chronic hepatitis B

artículo científico publicado en 2010

Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine Therapy.

artículo científico publicado en 2015

Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B

artículo científico publicado en 2019

Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy

artículo científico publicado en 2017

Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B

artículo científico publicado en 2019

Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues-authors' reply

artículo científico publicado en 2020

Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C-can one size fit all?

artículo científico publicado en 2018

Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis ⬇️

artículo científico publicado en 2016

Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients

artículo científico publicado en 2017

Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors.

artículo científico publicado en 2005

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy

artículo científico publicado en 2017

Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucles(t)ide analogues

artículo científico publicado en 2020

Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

artículo científico publicado en 2017

Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China.

artículo científico publicado en 2014

Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.

artículo científico publicado en 2011

Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: the emerging role of non-viral risk factors

scientific article published on 15 July 2020

Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents

artículo científico publicado en 2016

Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy.

artículo científico publicado en 2017

Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B.

artículo científico publicado en 2017

Improvements in the management of chronic hepatitis B virus infection

artículo científico publicado en 2018

Interleukin-21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection

artículo científico publicado en 2019

Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease

artículo científico publicado en 2011

Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.

artículo científico publicado en 2017

Letter to the Editor: Can the ratio of serum HBV RNA to DNA reflect the reverse transcription efficiency of viral pgRNA?

artículo científico publicado en 2020

Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients

artículo científico publicado en 2019

Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B

artículo científico publicado en 2017

Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B

artículo científico publicado en 2019

Management of chronic hepatitis B: experience from China.

artículo científico publicado en 2010

Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroco

artículo científico publicado en 2015

Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy

artículo científico publicado en 2015

Novel evidence of HBV recombination in family cluster infections in western China

artículo científico publicado en 2012

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

artículo científico publicado en 2005

Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study.

artículo científico publicado en 2017

Oral wounds and hepatitis B virus transmission

artículo científico publicado en 2014

Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B.

artículo científico publicado en 2015

Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross-sectional survey.

artículo científico publicado en 2017

Prevention and management of drug resistant hepatitis B virus infections.

artículo científico publicado en 2012

Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.

artículo científico publicado en 2013

Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

artículo científico publicado en 2003

Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

artículo científico publicado en 2011

Rapid Turnover of HBV cccDNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients

artículo científico publicado en 2020

Reply to Letter to the Editor: Why serum HBV DNA has higher frequency of rtM204I/V mutation than serum HBV RNA in the same individual?

scientific article published on 09 August 2020

Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B ⬇️

artículo científico publicado el 16 de diciembre de 2011

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

artículo científico publicado en 2020

Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection

artículo científico publicado en 2019

Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy

artículo científico publicado en 2018

Small surface antigen variants of HBV associated with responses to telbivudine treatment in chronic hepatitis B patients

artículo científico publicado en 2016

TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.

artículo científico publicado en 2014

The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.

artículo científico publicado en 2014

The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response.

artículo científico publicado en 2017

Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication

artículo científico publicado en 2017

qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients

artículo científico publicado en 2014

Lista de obras de

A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.

A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients

A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons.

Aberrant expression and dysfunction of TLR2 and its soluble form in chronic HBV infection and its regulation by antiviral therapy.

Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China

Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B.

Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Circulating chemokine (C-X-C Motif) receptor 5+CD4+ T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection ⬇️

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.

Combination Therapy With Tenofovir and Peginterferon May Not Be Translated Into Current Clinical Practice.

Commentary: prognostication of chronic hepatitis B ‐ are Fibrotest and Fibroscan the final answers? ⬇️

Complementarity-determining region 3 size spectratypes of T cell receptor beta chains in CD8+ T cells following antiviral treatment of chronic hepatitis B

Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine Therapy.

Development and validation of a model for hepatitis B e antigen seroconversion in entecavir-treated patients with chronic hepatitis B

Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy

Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B

Editorial: serum HBV RNA biphasic decline in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues-authors' reply

Editorial: sofosbuvir plus daclatasvir for the treatment of hepatitis C-can one size fit all?

Effect of Telbivudine Versus Other Nucleos(t)ide Analogs on HBeAg Seroconversion and Other Outcomes in Patients with Chronic Hepatitis B: A Network Meta-Analysis ⬇️

Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients

Effectiveness of prophylactic Anti-HBV therapy in allogeneic hematopoietic stem cell transplantation with HBsAg positive donors.

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy

Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucles(t)ide analogues

Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China.

Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.

Hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy: the emerging role of non-viral risk factors

Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents

Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy.

Improved performance of quantitative collagen parameters versus standard histology in longitudinal assessment of nonadvanced liver fibrosis for chronic hepatitis B.

Improvements in the management of chronic hepatitis B virus infection

Interleukin-21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection

Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease

Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.

Letter to the Editor: Can the ratio of serum HBV RNA to DNA reflect the reverse transcription efficiency of viral pgRNA?

Longitudinal Change of Body Mass Index Is Associated With Alanine Aminotransferase Elevation After Complete Viral Suppression in Chronic Hepatitis B Patients

Lower Expression of MicroRNA-155 Contributes to Dysfunction of Natural Killer Cells in Patients with Chronic Hepatitis B

Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B

Management of chronic hepatitis B: experience from China.

Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroco

Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy

Novel evidence of HBV recombination in family cluster infections in western China

Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area.

Off-Treatment Hepatitis B Virus (HBV) DNA Levels and the Prediction of Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B: A Prospective Stop Study.

Oral wounds and hepatitis B virus transmission

Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B.

Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross-sectional survey.

Prevention and management of drug resistant hepatitis B virus infections.

Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.

Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies.

Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

Rapid Turnover of HBV cccDNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients

Reply to Letter to the Editor: Why serum HBV DNA has higher frequency of rtM204I/V mutation than serum HBV RNA in the same individual?

Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B ⬇️

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Serum HBV RNA: a New Potential Biomarker for Chronic Hepatitis B Virus Infection

Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy

Small surface antigen variants of HBV associated with responses to telbivudine treatment in chronic hepatitis B patients

TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.

The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.

The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response.

Transforming growth factor β-activated kinase 1 transcriptionally suppresses hepatitis B virus replication

qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients